AustralieFrV1, PubMed, Curation, bibRecord, 000D31

Statin therapy for acute respiratory distress syndrome: an individual patient data meta-analysis of randomised clinical trials.

Identifieur interne : 000D31 ( PubMed/Curation ); précédent : 000D30; suivant : 000D32

Statin therapy for acute respiratory distress syndrome: an individual patient data meta-analysis of randomised clinical trials.

Auteurs : Myura Nagendran [Royaume-Uni] ; Daniel F. Mcauley [Royaume-Uni] ; Peter S. Kruger [Australie] ; Laurent Papazian [France] ; Jonathon D. Truwit [États-Unis] ; John G. Laffey [Canada] ; B Taylor Thompson [États-Unis] ; Mike Clarke [Royaume-Uni] ; Anthony C. Gordon [Royaume-Uni]

Source :

Intensive care medicine [ 1432-1238 ] ; 2017.

RBID : pubmed:28004129

Descripteurs français

KwdFr :
- Adulte, Analyse de régression, Creatine kinase (sang), Essais contrôlés randomisés comme sujet, Femelle, Humains, Inhibiteurs de l'hydroxyméthylglutaryl-CoA réductase (usage thérapeutique), Mâle, Résultat thérapeutique, Syndrome de détresse respiratoire de l'adulte (enzymologie), Syndrome de détresse respiratoire de l'adulte (mortalité), Syndrome de détresse respiratoire de l'adulte (traitement médicamenteux), Transaminases (sang).
MESH :
- enzymologie : Syndrome de détresse respiratoire de l'adulte.
- mortalité : Syndrome de détresse respiratoire de l'adulte.
- sang : Creatine kinase, Transaminases.
- traitement médicamenteux : Syndrome de détresse respiratoire de l'adulte.
- usage thérapeutique : Inhibiteurs de l'hydroxyméthylglutaryl-CoA réductase.
- Adulte, Analyse de régression, Essais contrôlés randomisés comme sujet, Femelle, Humains, Mâle, Résultat thérapeutique.

English descriptors

KwdEn :
- Adult, Creatine Kinase (blood), Female, Humans, Hydroxymethylglutaryl-CoA Reductase Inhibitors (therapeutic use), Male, Randomized Controlled Trials as Topic, Regression Analysis, Respiratory Distress Syndrome, Adult (drug therapy), Respiratory Distress Syndrome, Adult (enzymology), Respiratory Distress Syndrome, Adult (mortality), Transaminases (blood), Treatment Outcome.
MESH :
- chemical , blood : Creatine Kinase, Transaminases.
- chemical , therapeutic use : Hydroxymethylglutaryl-CoA Reductase Inhibitors.
- drug therapy : Respiratory Distress Syndrome, Adult.
- enzymology : Respiratory Distress Syndrome, Adult.
- mortality : Respiratory Distress Syndrome, Adult.
- Adult, Female, Humans, Male, Randomized Controlled Trials as Topic, Regression Analysis, Treatment Outcome.

Abstract

We performed an individual patient data meta-analysis to assess the possible benefits and harms of statin therapy in adults with acute respiratory distress syndrome (ARDS) and to investigate effects in specific ARDS subgroups.

DOI: 10.1007/s00134-016-4649-0
PubMed: 28004129

Links toward previous steps (curation, corpus...)

to stream PubMed, to step Corpus: Pour aller vers cette notice dans l'étape Curation :000D34

Links to Exploration step

pubmed:28004129

Le document en format XML

<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Statin therapy for acute respiratory distress syndrome: an individual patient data meta-analysis of randomised clinical trials.</title>
<author><name sortKey="Nagendran, Myura" sort="Nagendran, Myura" uniqKey="Nagendran M" first="Myura" last="Nagendran">Myura Nagendran</name>
<affiliation wicri:level="1"><nlm:affiliation>Section of Anaesthetics, Pain Medicine and Intensive Care, Department of Surgery and Cancer, Imperial College London and Charing Cross Hospital, Fulham Palace Road, London, W6 8RF, UK.</nlm:affiliation>
<country xml:lang="fr">Royaume-Uni</country>
<wicri:regionArea>Section of Anaesthetics, Pain Medicine and Intensive Care, Department of Surgery and Cancer, Imperial College London and Charing Cross Hospital, Fulham Palace Road, London, W6 8RF</wicri:regionArea>
</affiliation>
</author>
<author><name sortKey="Mcauley, Daniel F" sort="Mcauley, Daniel F" uniqKey="Mcauley D" first="Daniel F" last="Mcauley">Daniel F. Mcauley</name>
<affiliation wicri:level="1"><nlm:affiliation>School of Medicine, Dentistry and Biomedical Sciences, Queen's University of Belfast, Belfast, UK.</nlm:affiliation>
<country xml:lang="fr">Royaume-Uni</country>
<wicri:regionArea>School of Medicine, Dentistry and Biomedical Sciences, Queen's University of Belfast, Belfast</wicri:regionArea>
</affiliation>
</author>
<author><name sortKey="Kruger, Peter S" sort="Kruger, Peter S" uniqKey="Kruger P" first="Peter S" last="Kruger">Peter S. Kruger</name>
<affiliation wicri:level="1"><nlm:affiliation>Princess Alexandra Hospital, Metro South Health, Woolloongabba, QLD, Australia.</nlm:affiliation>
<country xml:lang="fr">Australie</country>
<wicri:regionArea>Princess Alexandra Hospital, Metro South Health, Woolloongabba, QLD</wicri:regionArea>
</affiliation>
</author>
<author><name sortKey="Papazian, Laurent" sort="Papazian, Laurent" uniqKey="Papazian L" first="Laurent" last="Papazian">Laurent Papazian</name>
<affiliation wicri:level="1"><nlm:affiliation>Medical Intensive Care Unit, North Hospital, Aix-Marseille University, Marseille, France.</nlm:affiliation>
<country xml:lang="fr">France</country>
<wicri:regionArea>Medical Intensive Care Unit, North Hospital, Aix-Marseille University, Marseille</wicri:regionArea>
</affiliation>
</author>
<author><name sortKey="Truwit, Jonathon D" sort="Truwit, Jonathon D" uniqKey="Truwit J" first="Jonathon D" last="Truwit">Jonathon D. Truwit</name>
<affiliation wicri:level="1"><nlm:affiliation>Pulmonary and Critical Care Medicine, Froedtert and Medical College of Wisconsin, Milwaukee, WI, USA.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Pulmonary and Critical Care Medicine, Froedtert and Medical College of Wisconsin, Milwaukee, WI</wicri:regionArea>
</affiliation>
</author>
<author><name sortKey="Laffey, John G" sort="Laffey, John G" uniqKey="Laffey J" first="John G" last="Laffey">John G. Laffey</name>
<affiliation wicri:level="1"><nlm:affiliation>Departments of Anesthesia and Critical Care Medicine, St Michael's Hospital, University of Toronto, Toronto, Canada.</nlm:affiliation>
<country xml:lang="fr">Canada</country>
<wicri:regionArea>Departments of Anesthesia and Critical Care Medicine, St Michael's Hospital, University of Toronto, Toronto</wicri:regionArea>
</affiliation>
</author>
<author><name sortKey="Thompson, B Taylor" sort="Thompson, B Taylor" uniqKey="Thompson B" first="B Taylor" last="Thompson">B Taylor Thompson</name>
<affiliation wicri:level="1"><nlm:affiliation>Division of Pulmonary and Critical Care Medicine, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Division of Pulmonary and Critical Care Medicine, Massachusetts General Hospital and Harvard Medical School, Boston, MA</wicri:regionArea>
</affiliation>
</author>
<author><name sortKey="Clarke, Mike" sort="Clarke, Mike" uniqKey="Clarke M" first="Mike" last="Clarke">Mike Clarke</name>
<affiliation wicri:level="1"><nlm:affiliation>School of Medicine, Dentistry and Biomedical Sciences, Queen's University of Belfast, Belfast, UK.</nlm:affiliation>
<country xml:lang="fr">Royaume-Uni</country>
<wicri:regionArea>School of Medicine, Dentistry and Biomedical Sciences, Queen's University of Belfast, Belfast</wicri:regionArea>
</affiliation>
</author>
<author><name sortKey="Gordon, Anthony C" sort="Gordon, Anthony C" uniqKey="Gordon A" first="Anthony C" last="Gordon">Anthony C. Gordon</name>
<affiliation wicri:level="1"><nlm:affiliation>Section of Anaesthetics, Pain Medicine and Intensive Care, Department of Surgery and Cancer, Imperial College London and Charing Cross Hospital, Fulham Palace Road, London, W6 8RF, UK. anthony.gordon@imperial.ac.uk.</nlm:affiliation>
<country xml:lang="fr">Royaume-Uni</country>
<wicri:regionArea>Section of Anaesthetics, Pain Medicine and Intensive Care, Department of Surgery and Cancer, Imperial College London and Charing Cross Hospital, Fulham Palace Road, London, W6 8RF</wicri:regionArea>
</affiliation>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">PubMed</idno>
<date when="2017">2017</date>
<idno type="RBID">pubmed:28004129</idno>
<idno type="pmid">28004129</idno>
<idno type="doi">10.1007/s00134-016-4649-0</idno>
<idno type="wicri:Area/PubMed/Corpus">000D34</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">000D34</idno>
<idno type="wicri:Area/PubMed/Curation">000D31</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">000D31</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en">Statin therapy for acute respiratory distress syndrome: an individual patient data meta-analysis of randomised clinical trials.</title>
<author><name sortKey="Nagendran, Myura" sort="Nagendran, Myura" uniqKey="Nagendran M" first="Myura" last="Nagendran">Myura Nagendran</name>
<affiliation wicri:level="1"><nlm:affiliation>Section of Anaesthetics, Pain Medicine and Intensive Care, Department of Surgery and Cancer, Imperial College London and Charing Cross Hospital, Fulham Palace Road, London, W6 8RF, UK.</nlm:affiliation>
<country xml:lang="fr">Royaume-Uni</country>
<wicri:regionArea>Section of Anaesthetics, Pain Medicine and Intensive Care, Department of Surgery and Cancer, Imperial College London and Charing Cross Hospital, Fulham Palace Road, London, W6 8RF</wicri:regionArea>
</affiliation>
</author>
<author><name sortKey="Mcauley, Daniel F" sort="Mcauley, Daniel F" uniqKey="Mcauley D" first="Daniel F" last="Mcauley">Daniel F. Mcauley</name>
<affiliation wicri:level="1"><nlm:affiliation>School of Medicine, Dentistry and Biomedical Sciences, Queen's University of Belfast, Belfast, UK.</nlm:affiliation>
<country xml:lang="fr">Royaume-Uni</country>
<wicri:regionArea>School of Medicine, Dentistry and Biomedical Sciences, Queen's University of Belfast, Belfast</wicri:regionArea>
</affiliation>
</author>
<author><name sortKey="Kruger, Peter S" sort="Kruger, Peter S" uniqKey="Kruger P" first="Peter S" last="Kruger">Peter S. Kruger</name>
<affiliation wicri:level="1"><nlm:affiliation>Princess Alexandra Hospital, Metro South Health, Woolloongabba, QLD, Australia.</nlm:affiliation>
<country xml:lang="fr">Australie</country>
<wicri:regionArea>Princess Alexandra Hospital, Metro South Health, Woolloongabba, QLD</wicri:regionArea>
</affiliation>
</author>
<author><name sortKey="Papazian, Laurent" sort="Papazian, Laurent" uniqKey="Papazian L" first="Laurent" last="Papazian">Laurent Papazian</name>
<affiliation wicri:level="1"><nlm:affiliation>Medical Intensive Care Unit, North Hospital, Aix-Marseille University, Marseille, France.</nlm:affiliation>
<country xml:lang="fr">France</country>
<wicri:regionArea>Medical Intensive Care Unit, North Hospital, Aix-Marseille University, Marseille</wicri:regionArea>
</affiliation>
</author>
<author><name sortKey="Truwit, Jonathon D" sort="Truwit, Jonathon D" uniqKey="Truwit J" first="Jonathon D" last="Truwit">Jonathon D. Truwit</name>
<affiliation wicri:level="1"><nlm:affiliation>Pulmonary and Critical Care Medicine, Froedtert and Medical College of Wisconsin, Milwaukee, WI, USA.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Pulmonary and Critical Care Medicine, Froedtert and Medical College of Wisconsin, Milwaukee, WI</wicri:regionArea>
</affiliation>
</author>
<author><name sortKey="Laffey, John G" sort="Laffey, John G" uniqKey="Laffey J" first="John G" last="Laffey">John G. Laffey</name>
<affiliation wicri:level="1"><nlm:affiliation>Departments of Anesthesia and Critical Care Medicine, St Michael's Hospital, University of Toronto, Toronto, Canada.</nlm:affiliation>
<country xml:lang="fr">Canada</country>
<wicri:regionArea>Departments of Anesthesia and Critical Care Medicine, St Michael's Hospital, University of Toronto, Toronto</wicri:regionArea>
</affiliation>
</author>
<author><name sortKey="Thompson, B Taylor" sort="Thompson, B Taylor" uniqKey="Thompson B" first="B Taylor" last="Thompson">B Taylor Thompson</name>
<affiliation wicri:level="1"><nlm:affiliation>Division of Pulmonary and Critical Care Medicine, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Division of Pulmonary and Critical Care Medicine, Massachusetts General Hospital and Harvard Medical School, Boston, MA</wicri:regionArea>
</affiliation>
</author>
<author><name sortKey="Clarke, Mike" sort="Clarke, Mike" uniqKey="Clarke M" first="Mike" last="Clarke">Mike Clarke</name>
<affiliation wicri:level="1"><nlm:affiliation>School of Medicine, Dentistry and Biomedical Sciences, Queen's University of Belfast, Belfast, UK.</nlm:affiliation>
<country xml:lang="fr">Royaume-Uni</country>
<wicri:regionArea>School of Medicine, Dentistry and Biomedical Sciences, Queen's University of Belfast, Belfast</wicri:regionArea>
</affiliation>
</author>
<author><name sortKey="Gordon, Anthony C" sort="Gordon, Anthony C" uniqKey="Gordon A" first="Anthony C" last="Gordon">Anthony C. Gordon</name>
<affiliation wicri:level="1"><nlm:affiliation>Section of Anaesthetics, Pain Medicine and Intensive Care, Department of Surgery and Cancer, Imperial College London and Charing Cross Hospital, Fulham Palace Road, London, W6 8RF, UK. anthony.gordon@imperial.ac.uk.</nlm:affiliation>
<country xml:lang="fr">Royaume-Uni</country>
<wicri:regionArea>Section of Anaesthetics, Pain Medicine and Intensive Care, Department of Surgery and Cancer, Imperial College London and Charing Cross Hospital, Fulham Palace Road, London, W6 8RF</wicri:regionArea>
</affiliation>
</author>
</analytic>
<series><title level="j">Intensive care medicine</title>
<idno type="eISSN">1432-1238</idno>
<imprint><date when="2017" type="published">2017</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Adult</term>
<term>Creatine Kinase (blood)</term>
<term>Female</term>
<term>Humans</term>
<term>Hydroxymethylglutaryl-CoA Reductase Inhibitors (therapeutic use)</term>
<term>Male</term>
<term>Randomized Controlled Trials as Topic</term>
<term>Regression Analysis</term>
<term>Respiratory Distress Syndrome, Adult (drug therapy)</term>
<term>Respiratory Distress Syndrome, Adult (enzymology)</term>
<term>Respiratory Distress Syndrome, Adult (mortality)</term>
<term>Transaminases (blood)</term>
<term>Treatment Outcome</term>
</keywords>
<keywords scheme="KwdFr" xml:lang="fr"><term>Adulte</term>
<term>Analyse de régression</term>
<term>Creatine kinase (sang)</term>
<term>Essais contrôlés randomisés comme sujet</term>
<term>Femelle</term>
<term>Humains</term>
<term>Inhibiteurs de l'hydroxyméthylglutaryl-CoA réductase (usage thérapeutique)</term>
<term>Mâle</term>
<term>Résultat thérapeutique</term>
<term>Syndrome de détresse respiratoire de l'adulte (enzymologie)</term>
<term>Syndrome de détresse respiratoire de l'adulte (mortalité)</term>
<term>Syndrome de détresse respiratoire de l'adulte (traitement médicamenteux)</term>
<term>Transaminases (sang)</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="blood" xml:lang="en"><term>Creatine Kinase</term>
<term>Transaminases</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="therapeutic use" xml:lang="en"><term>Hydroxymethylglutaryl-CoA Reductase Inhibitors</term>
</keywords>
<keywords scheme="MESH" qualifier="drug therapy" xml:lang="en"><term>Respiratory Distress Syndrome, Adult</term>
</keywords>
<keywords scheme="MESH" qualifier="enzymologie" xml:lang="fr"><term>Syndrome de détresse respiratoire de l'adulte</term>
</keywords>
<keywords scheme="MESH" qualifier="enzymology" xml:lang="en"><term>Respiratory Distress Syndrome, Adult</term>
</keywords>
<keywords scheme="MESH" qualifier="mortality" xml:lang="en"><term>Respiratory Distress Syndrome, Adult</term>
</keywords>
<keywords scheme="MESH" qualifier="mortalité" xml:lang="fr"><term>Syndrome de détresse respiratoire de l'adulte</term>
</keywords>
<keywords scheme="MESH" qualifier="sang" xml:lang="fr"><term>Creatine kinase</term>
<term>Transaminases</term>
</keywords>
<keywords scheme="MESH" qualifier="traitement médicamenteux" xml:lang="fr"><term>Syndrome de détresse respiratoire de l'adulte</term>
</keywords>
<keywords scheme="MESH" qualifier="usage thérapeutique" xml:lang="fr"><term>Inhibiteurs de l'hydroxyméthylglutaryl-CoA réductase</term>
</keywords>
<keywords scheme="MESH" xml:lang="en"><term>Adult</term>
<term>Female</term>
<term>Humans</term>
<term>Male</term>
<term>Randomized Controlled Trials as Topic</term>
<term>Regression Analysis</term>
<term>Treatment Outcome</term>
</keywords>
<keywords scheme="MESH" xml:lang="fr"><term>Adulte</term>
<term>Analyse de régression</term>
<term>Essais contrôlés randomisés comme sujet</term>
<term>Femelle</term>
<term>Humains</term>
<term>Mâle</term>
<term>Résultat thérapeutique</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en">We performed an individual patient data meta-analysis to assess the possible benefits and harms of statin therapy in adults with acute respiratory distress syndrome (ARDS) and to investigate effects in specific ARDS subgroups.</div>
</front>
</TEI>
<pubmed><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">28004129</PMID>
<DateCreated><Year>2016</Year>
<Month>12</Month>
<Day>22</Day>
</DateCreated>
<DateCompleted><Year>2017</Year>
<Month>09</Month>
<Day>14</Day>
</DateCompleted>
<DateRevised><Year>2017</Year>
<Month>09</Month>
<Day>22</Day>
</DateRevised>
<Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1432-1238</ISSN>
<JournalIssue CitedMedium="Internet"><Volume>43</Volume>
<Issue>5</Issue>
<PubDate><Year>2017</Year>
<Month>May</Month>
</PubDate>
</JournalIssue>
<Title>Intensive care medicine</Title>
<ISOAbbreviation>Intensive Care Med</ISOAbbreviation>
</Journal>
<ArticleTitle>Statin therapy for acute respiratory distress syndrome: an individual patient data meta-analysis of randomised clinical trials.</ArticleTitle>
<Pagination><MedlinePgn>663-671</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1007/s00134-016-4649-0</ELocationID>
<Abstract><AbstractText Label="PURPOSE" NlmCategory="OBJECTIVE">We performed an individual patient data meta-analysis to assess the possible benefits and harms of statin therapy in adults with acute respiratory distress syndrome (ARDS) and to investigate effects in specific ARDS subgroups.</AbstractText>
<AbstractText Label="METHODS" NlmCategory="METHODS">We identified randomised clinical trials up to 31 October 2016 that had investigated statin therapy versus placebo in patients with ARDS. Individual patient data from each trial were compiled. Conventional two-stage meta-analyses were performed for primary and secondary outcomes, and one-stage regression models with single treatment-covariate interactions for subgroup analyses. Risk of bias was assessed using the Cochrane Risk of Bias Tool.</AbstractText>
<AbstractText Label="RESULTS" NlmCategory="RESULTS">Six trials with a total of 1755 patients were included. For the primary outcomes, there was no significant effect of statin therapy on 28-day mortality [relative risk (RR) 1.03, 95% CI 0.86-1.23], ventilator-free days (mean difference 0.34 days, 95% CI -0.68 to 1.36) or serious adverse events (RR 1.14, 95% CI 0.84-1.53). There was a significantly increased incidence of raised serum creatine kinase or transaminase levels with statin therapy (106/879; 12.1%) versus control (78/876; 8.9%) (RR 1.40, 95% CI 1.07-1.83, p = 0.015). There were no significant treatment-covariate interactions in the predefined subgroups investigated.</AbstractText>
<AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">We found no clinical benefit from initiation of statin therapy in adult patients with ARDS, either overall or in predefined subgroups. While there was an increased incidence of raised serum creatine kinase and transaminase levels, there was no difference in serious adverse events among groups. Therefore, we do not recommend initiation of statin therapy for the treatment of ARDS.</AbstractText>
</Abstract>
<AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Nagendran</LastName>
<ForeName>Myura</ForeName>
<Initials>M</Initials>
<AffiliationInfo><Affiliation>Section of Anaesthetics, Pain Medicine and Intensive Care, Department of Surgery and Cancer, Imperial College London and Charing Cross Hospital, Fulham Palace Road, London, W6 8RF, UK.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>McAuley</LastName>
<ForeName>Daniel F</ForeName>
<Initials>DF</Initials>
<AffiliationInfo><Affiliation>School of Medicine, Dentistry and Biomedical Sciences, Queen's University of Belfast, Belfast, UK.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Kruger</LastName>
<ForeName>Peter S</ForeName>
<Initials>PS</Initials>
<AffiliationInfo><Affiliation>Princess Alexandra Hospital, Metro South Health, Woolloongabba, QLD, Australia.</Affiliation>
</AffiliationInfo>
<AffiliationInfo><Affiliation>School of Medicine, University of Queensland, Brisbane, Australia.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Papazian</LastName>
<ForeName>Laurent</ForeName>
<Initials>L</Initials>
<AffiliationInfo><Affiliation>Medical Intensive Care Unit, North Hospital, Aix-Marseille University, Marseille, France.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Truwit</LastName>
<ForeName>Jonathon D</ForeName>
<Initials>JD</Initials>
<AffiliationInfo><Affiliation>Pulmonary and Critical Care Medicine, Froedtert and Medical College of Wisconsin, Milwaukee, WI, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Laffey</LastName>
<ForeName>John G</ForeName>
<Initials>JG</Initials>
<AffiliationInfo><Affiliation>Departments of Anesthesia and Critical Care Medicine, St Michael's Hospital, University of Toronto, Toronto, Canada.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Thompson</LastName>
<ForeName>B Taylor</ForeName>
<Initials>BT</Initials>
<AffiliationInfo><Affiliation>Division of Pulmonary and Critical Care Medicine, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Clarke</LastName>
<ForeName>Mike</ForeName>
<Initials>M</Initials>
<AffiliationInfo><Affiliation>School of Medicine, Dentistry and Biomedical Sciences, Queen's University of Belfast, Belfast, UK.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Gordon</LastName>
<ForeName>Anthony C</ForeName>
<Initials>AC</Initials>
<AffiliationInfo><Affiliation>Section of Anaesthetics, Pain Medicine and Intensive Care, Department of Surgery and Cancer, Imperial College London and Charing Cross Hospital, Fulham Palace Road, London, W6 8RF, UK. anthony.gordon@imperial.ac.uk.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<GrantList CompleteYN="Y"><Grant><GrantID>MC_G1002460</GrantID>
<Agency>Medical Research Council</Agency>
<Country>United Kingdom</Country>
</Grant>
</GrantList>
<PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType>
<PublicationType UI="D017418">Meta-Analysis</PublicationType>
<PublicationType UI="D016454">Review</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic"><Year>2016</Year>
<Month>12</Month>
<Day>21</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo><Country>United States</Country>
<MedlineTA>Intensive Care Med</MedlineTA>
<NlmUniqueID>7704851</NlmUniqueID>
<ISSNLinking>0342-4642</ISSNLinking>
</MedlineJournalInfo>
<ChemicalList><Chemical><RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D019161">Hydroxymethylglutaryl-CoA Reductase Inhibitors</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>EC 2.6.1.-</RegistryNumber>
<NameOfSubstance UI="D000637">Transaminases</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>EC 2.7.3.2</RegistryNumber>
<NameOfSubstance UI="D003402">Creatine Kinase</NameOfSubstance>
</Chemical>
</ChemicalList>
<CitationSubset>IM</CitationSubset>
<CommentsCorrectionsList><CommentsCorrections RefType="Cites"><RefSource>JAMA. 2013 Oct 23;310(16):1692-700</RefSource>
<PMID Version="1">24108510</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Ann Surg. 2014 Jan;259(1):26-31</RefSource>
<PMID Version="1">23817506</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Intensive Care Med. 2006 Apr;32(4):545-52</RefSource>
<PMID Version="1">16501946</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Am J Respir Crit Care Med. 1994 Mar;149(3 Pt 1):818-24</RefSource>
<PMID Version="1">7509706</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>J Clin Epidemiol. 2011 Sep;64(9):949-67</RefSource>
<PMID Version="1">21411280</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>N Engl J Med. 2005 Oct 20;353(16):1685-93</RefSource>
<PMID Version="1">16236739</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Am J Respir Crit Care Med. 2006 Sep 1;174(5):538-44</RefSource>
<PMID Version="1">16763220</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Am J Respir Crit Care Med. 2009 Jun 15;179(12):1107-14</RefSource>
<PMID Version="1">19324974</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Intensive Care Med. 2006 Jan;32(1):75-9</RefSource>
<PMID Version="1">16283159</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Am J Med. 2015 Apr;128(4):410-7.e1</RefSource>
<PMID Version="1">25526798</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>BMC Clin Pharmacol. 2012 Jun 28;12 :13</RefSource>
<PMID Version="1">22742644</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Minerva Anestesiol. 2015 Aug;81(8):921-30</RefSource>
<PMID Version="1">25690048</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Am J Respir Crit Care Med. 2013 Apr 1;187(7):672-4</RefSource>
<PMID Version="1">23540874</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>BMJ. 2010 Feb 05;340:c221</RefSource>
<PMID Version="1">20139215</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Shock. 2016 Jan;45(1):10-5</RefSource>
<PMID Version="1">26674450</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>N Engl J Med. 2011 Apr 7;364(14):1293-304</RefSource>
<PMID Version="1">21470008</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>PLoS One. 2012;7(10):e46042</RefSource>
<PMID Version="1">23056232</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Intensive Care Med. 2017 May;43(5):675-676</RefSource>
<PMID Version="1">27752737</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>N Engl J Med. 2014 Jun 5;370(23):2191-200</RefSource>
<PMID Version="1">24835849</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Intensive Care Med. 2017 May;43(5):672-674</RefSource>
<PMID Version="1">27752735</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Ann Intensive Care. 2015 May 06;5:9</RefSource>
<PMID Version="1">25992302</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>JAMA. 2016 Feb 23;315(8):788-800</RefSource>
<PMID Version="1">26903337</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Arch Intern Med. 2009 Oct 12;169(18):1658-67</RefSource>
<PMID Version="1">19822822</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>J Antimicrob Chemother. 2008 Apr;61(4):774-85</RefSource>
<PMID Version="1">18263570</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Am J Respir Crit Care Med. 2014 Mar 15;189(6):666-73</RefSource>
<PMID Version="1">24417431</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Lancet Infect Dis. 2006 Apr;6(4):242-8</RefSource>
<PMID Version="1">16554249</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Am J Respir Crit Care Med. 2011 Mar 15;183(6):774-81</RefSource>
<PMID Version="1">20959555</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Intensive Care Med. 2017 May;43(5):677-679</RefSource>
<PMID Version="1">27752736</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Clin Microbiol Infect. 2009 Apr;15(4):325-34</RefSource>
<PMID Version="1">19416304</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Am J Respir Crit Care Med. 2013 Apr 1;187(7):743-50</RefSource>
<PMID Version="1">23348980</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>BMC Med. 2015 Jun 01;13:128</RefSource>
<PMID Version="1">26033076</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Cochrane Database Syst Rev. 2011 Aug 10;(8):MR000026</RefSource>
<PMID Version="1">21833989</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>J Crit Care. 2014 Oct;29(5):886.e9-15</RefSource>
<PMID Version="1">24996762</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Lancet. 2016 Nov 12;388(10058):2416-2430</RefSource>
<PMID Version="1">27133972</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Am J Physiol Lung Cell Mol Physiol. 2005 Jun;288(6):L1026-32</RefSource>
<PMID Version="1">15665042</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Lancet Respir Med. 2014 Aug;2(8):611-20</RefSource>
<PMID Version="1">24853585</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Crit Care Med. 2011 Nov;39(11):2440-6</RefSource>
<PMID Version="1">21725239</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>BMJ. 2011 Oct 18;343:d5928</RefSource>
<PMID Version="1">22008217</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>N Engl J Med. 2014 Oct 30;371(18):1695-703</RefSource>
<PMID Version="1">25268516</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Am J Respir Crit Care Med. 2011 Mar 1;183(5):620-6</RefSource>
<PMID Version="1">20870757</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Trials. 2015 Aug 20;16:368</RefSource>
<PMID Version="1">26289560</PMID>
</CommentsCorrections>
</CommentsCorrectionsList>
<MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D003402" MajorTopicYN="N">Creatine Kinase</DescriptorName>
<QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D019161" MajorTopicYN="N">Hydroxymethylglutaryl-CoA Reductase Inhibitors</DescriptorName>
<QualifierName UI="Q000627" MajorTopicYN="Y">therapeutic use</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D016032" MajorTopicYN="Y">Randomized Controlled Trials as Topic</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D012044" MajorTopicYN="N">Regression Analysis</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D012128" MajorTopicYN="N">Respiratory Distress Syndrome, Adult</DescriptorName>
<QualifierName UI="Q000188" MajorTopicYN="Y">drug therapy</QualifierName>
<QualifierName UI="Q000201" MajorTopicYN="N">enzymology</QualifierName>
<QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D000637" MajorTopicYN="N">Transaminases</DescriptorName>
<QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D016896" MajorTopicYN="N">Treatment Outcome</DescriptorName>
</MeshHeading>
</MeshHeadingList>
<KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">ALI</Keyword>
<Keyword MajorTopicYN="N">ARDS</Keyword>
<Keyword MajorTopicYN="N">Meta-analysis</Keyword>
<Keyword MajorTopicYN="N">Statin</Keyword>
</KeywordList>
</MedlineCitation>
<PubmedData><History><PubMedPubDate PubStatus="received"><Year>2016</Year>
<Month>09</Month>
<Day>25</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="accepted"><Year>2016</Year>
<Month>12</Month>
<Day>08</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="pubmed"><Year>2016</Year>
<Month>12</Month>
<Day>23</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="medline"><Year>2017</Year>
<Month>9</Month>
<Day>15</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="entrez"><Year>2016</Year>
<Month>12</Month>
<Day>23</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
</History>
<PublicationStatus>ppublish</PublicationStatus>
<ArticleIdList><ArticleId IdType="pubmed">28004129</ArticleId>
<ArticleId IdType="doi">10.1007/s00134-016-4649-0</ArticleId>
<ArticleId IdType="pii">10.1007/s00134-016-4649-0</ArticleId>
</ArticleIdList>
</PubmedData>
</pubmed>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Asie/explor/AustralieFrV1/Data/PubMed/Curation

HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000D31 | SxmlIndent | more

HfdSelect -h $EXPLOR_AREA/Data/PubMed/Curation/biblio.hfd -nk 000D31 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Asie
   |area=    AustralieFrV1
   |flux=    PubMed
   |étape=   Curation
   |type=    RBID
   |clé=     pubmed:28004129
   |texte=   Statin therapy for acute respiratory distress syndrome: an individual patient data meta-analysis of randomised clinical trials.
}}

Pour générer des pages wiki

HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Curation/RBID.i   -Sk "pubmed:28004129" \
       | HfdSelect -Kh $EXPLOR_AREA/Data/PubMed/Curation/biblio.hfd   \
       | NlmPubMed2Wicri -a AustralieFrV1

This area was generated with Dilib version V0.6.33.
Data generation: Tue Dec 5 10:43:12 2017. Site generation: Tue Mar 5 14:07:20 2024

	Serveur d'exploration sur les relations entre la France et l'Australie
	Attention, ce site est en cours de développement ! Attention, site généré par des moyens informatiques à partir de corpus bruts. Les informations ne sont donc pas validées.

Serveur d'exploration sur les relations entre la France et l'Australie

Statin therapy for acute respiratory distress syndrome: an individual patient data meta-analysis of randomised clinical trials.

Statin therapy for acute respiratory distress syndrome: an individual patient data meta-analysis of randomised clinical trials.

Source :

Descripteurs français

English descriptors

Abstract

Links toward previous steps (curation, corpus...)

Links to Exploration step

Le document en format XML

Pour manipuler ce document sous Unix (Dilib)

Pour mettre un lien sur cette page dans le réseau Wicri

Pour générer des pages wiki